Who
Irwin D. Simon
President and CEO
Company insider
Files Form 4 as: President and CEO, Tilray Brands; Director, Stagwell; Director, Whole Earth Brands; Director, Barnes & Noble; Pres., CEO & Chairman of Bd, The Hain Celestial Group; Director, Jarden; Director, Marathon Acquisition.
In numbers
- Trades disclosed
- 405
- Buys
- 8
- Sells
- 52
- Bought
- $2.7M
- Sold
- $131.7M
- Companies
- 7
- Companies where not an officer
- 5
- First trade
- 5 May 2006
- Last trade
- 26 Aug 2026
- Last filed
- 27 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code M | —408,605 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code F | $1.1M216,561 at $4.88 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code M | —803,563 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray Brandsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —408,605 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray Brandsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —803,563 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code F | $2.1M425,889 at $4.88 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray Brandsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —408,605 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray Brandsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —803,563 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code M | —408,605 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code F | $1.1M216,561 at $4.88 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code M | —803,563 at $0.00 | filing |
| 26 Aug 2026filed 27 Aug 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code F | $2.1M425,889 at $4.88 | filing |
| 30 Jul 2026filed 31 Jul 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code M | —117,647 at $0.00 | filing |
| 30 Jul 2026filed 31 Jul 2026 | TLRY Tilray Brandsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —117,647 at $0.00 | filing |
| 30 Jul 2026filed 31 Jul 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code F | $262K62,353 at $4.20 | filing |
| 30 Jul 2026filed 31 Jul 2026 | TLRY Tilray Brandsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —117,647 at $0.00 | filing |
| 30 Jul 2026filed 31 Jul 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code M | —117,647 at $0.00 | filing |
| 30 Jul 2026filed 31 Jul 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code F | $262K62,353 at $4.20 | filing |
| 29 Jul 2026filed 31 Jul 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code M | —428,448 at $0.00 | filing |
| 29 Jul 2026filed 31 Jul 2026 | TLRY Tilray BrandsPharmaceuticals | SEC FORM 4 Code F | $906K227,078 at $3.99 | filing |
News
Hain Celestial Faces Bid To Revive Baby Food Labeling CaseHAIN · law360.com · 20 Oct 2026Analyzing Tilray Brands (NASDAQ:TLRY) and Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF)TLRY · tickerreport.com · 18 Oct 2026Contrasting Tilray Brands (NASDAQ:TLRY) and Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF)TLRY · dailypolitical.com · 18 Oct 2026Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?TLRY · fool.com · 15 Oct 2026Hain Celestial plunges on concern sale of international nusiness will be derailedHAIN · seekingalpha.com · 15 Oct 2026
0 headlines in the last 90 days name Irwin D. Simon; 5 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.